Shares of Star Health and Allied Insurance Company experienced a significant rise of 13.32% on the National Stock Exchange (NSE), reaching an intra-day high of ₹586.25 after the release of its financial results for the quarter and year ending March 31, 2026. By midday, the stock was trading at ₹537.40, reflecting a 3.89% increase from the previous close of ₹517.30. The company's profit after tax (PAT) for Q4 FY26 was reported at ₹911 crore, marking a 16% year-on-year growth, driven by premium growth and improved operational metrics. Star Health's gross written premium (GWP) for the fiscal year amounted to ₹20,369 crore, also reflecting a 16% year-on-year increase. The company maintained its leadership in the retail health insurance market, holding a 31% market share. The combined ratio improved to 98.8% from 101.1% in FY25, indicating enhanced operational efficiency. CEO Anand Roy highlighted the company's focus on prudent underwriting and digital adoption to improve customer experience. Brokerage firm Motilal Oswal Financial Services has a 'Buy' rating on Star Health, noting strong premium growth in Q4 FY26 and optimistic prospects for the company's future.